Multiple dose study of Prototype MK-0518 formulations(QBR115739)

• Research type

  Research Study

• Full title

  A Product Value Enhancement Multiple Dose Feasibility Study of Prototype MK-0518 Gastroretentive Formulations

• IRAS ID

  129188

• Contact name

  Philip Evans

• Contact email

  Phil.Evans@quotientclinical.com

• Sponsor organisation

  Merck, Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc.

• Eudract number

  2013-001159-11

• REC name

  HSC REC A

• REC reference

  13/NI/0059

• Date of REC Opinion

  17 May 2013

• REC opinion

  Further Information Favourable Opinion